Gefitinib in treatment of advanced non-small-cell lung cancer as a last treatment option on an Expanded Access Program

被引：0
|
作者：
Zemanova, M [1 ]
Petruzelka, L [1 ]
Honova, H [1 ]
Dvorak, J [1 ]
Safanda, M [1 ]
Mares, P [1 ]
Tomancova, V [1 ]
机构：
[1] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland
来源：
LUNG CANCER | 2004年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S82 / S83
页数：2
相关论文
共 50 条
  • [1] Gefitinib in treatment of advanced non-small-cell lung cancer as a last treatment option on an Expanded Access Program
    Zemanova, M
    Petruzelka, L
    Honova, H
    Dvorak, J
    Safanda, M
    Mares, P
    Tomancova, V
    LUNG CANCER, 2004, 45 : S82 - S82
  • [2] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [3] Gefitinib as a last treatment option for non-small-cell lung cancer: durable disease control in a subset of patients
    Haringhuizen, A
    van Tinteren, H
    Vaessen, HFR
    Baas, P
    van Zandwijk, N
    ANNALS OF ONCOLOGY, 2004, 15 (05) : 786 - 792
  • [4] Gefitinib for the treatment of non-small-cell lung cancer
    Campbell, Lynn
    Blackhall, Fiona
    Thatcher, Nicholas
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (08) : 1343 - 1357
  • [5] Gefitinib for the treatment of non-small-cell lung cancer
    Hida, Toyoaki
    Ogawa, Shizu
    Park, Jang Chul
    Park, Ji Young
    Shimizu, Junichi
    Horio, Yoshitsugu
    Yoshida, Kimihide
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (01) : 17 - 35
  • [6] Gefitinib for non-small-cell lung cancer treatment
    D'Incecco, Armida
    Cappuzzo, Federico
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (06) : 987 - 996
  • [7] Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib
    Cataldo, Vince D.
    Gibbons, Don L.
    Perez-Soler, Roman
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10): : 947 - 955
  • [8] Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer
    Rossi, Antonio
    La Salvia, Anna
    Di Maio, Massimo
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (03) : 171 - 180
  • [9] Community practice experience with gefitinib (ZD1839) as treatment for patients with advanced non-small-cell lung cancer (NSCLC) within an expanded access clinical program.
    Ervin, TJ
    Toothaker, SR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 707S - 707S
  • [10] Optimizing response to gefitinib in the treatment of non-small-cell lung cancer
    Carotenuto, Pietro
    Roma, Cristin
    Rachiglio, Anna Maria
    Pasquale, Raffaella
    Franco, Renato
    Antinolfi, Giuseppe
    Piantedosi, Francovito
    Illiano, Alfonso
    Botti, Gerardo
    Morabito, Alessandro
    Normanno, Nicola
    De Luca, Antonella
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2011, 4 : 1 - 9
12345